TRIP
37
-7
NUE
36
-5
WU
42
-6
NWL
41
-2
XYL
31
-4
UHS
64
-3
PYPL
16
-9
PFE
35
-2
ADI
47
-4
FLR
40
-8
WFC
69
-5
GWW
51
-9
TRV
49
-3
MCK
75
-2
KSS
21
-2
HSY
35
-2
DG
33
-7
BA
39
-5
NAVI
32
-4
AIV
46
3
TRIP
37
-7
NUE
36
-5
WU
42
-6
NWL
41
-2
XYL
31
-4
UHS
64
-3
PYPL
16
-9
PFE
35
-2
ADI
47
-4
FLR
40
-8
WFC
69
-5
GWW
51
-9
TRV
49
-3
MCK
75
-2
KSS
21
-2
HSY
35
-2
DG
33
-7
BA
39
-5
NAVI
32
-4
AIV
46
3
Financhill
Back

The Vita Coco 10K Form

Sell
33

COCO
The Vita Coco

Last Price:
$29.84
Seasonality Move:
26.82%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive COCO News And Ratings

See the #1 stock for the next 7 days that we like better than COCO

COCO Financial Statistics

Sales & Book Value

Annual Sales: $516M
Cash Flow: $6.8M
Price / Cash Flow: 42.21
Annual Sales: $4.54
Price / Book: 6.57

Profitability

EPS (TTM): 0.94000
Net Income (TTM): $56M
Gross Margin: $198.8M
Return on Equity: 24.22%
Return on Assets: 17.34%

The Vita Coco Earnings Forecast

Key The Vita Coco Financial Ratios

  • The Gross Profit Margin over the past 16 years for COCO is 38.52%.
  • The Selling, General & Administrative Expenses for COCO have been equal to 24.22% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of COCO is 10.84% of Total Revenues.
  • Per Share Earnings over the last 16 years have been positive in 9 years.

The Vita Coco Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Beverages
Sector: Consumer Staples
Current Symbol: COCO
CUSIP: 218868
Website: vitacoco.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.31
Quick Ratio: 2.38

Price-to-Earnings

Trailing P/E Ratio: 31.76
Forward P/E Ratio: 20.63

COCO Technical Analysis vs Fundamental Analysis

Sell
33
The Vita Coco (COCO) is a Sell

Is The Vita Coco a Buy or a Sell?

  • The Vita Coco stock is rated a Sell
    The current The Vita Coco [COCO] share price is $29.85. The Score for COCO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.